<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SpineJournal.gr &#187; nuvasive</title>
	<atom:link href="http://www.spinejournal.gr/tag/nuvasive/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.spinejournal.gr</link>
	<description></description>
	<lastBuildDate>Fri, 30 Jul 2010 08:02:58 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>NuVasive Reports First Quarter 2010 Financial Results</title>
		<link>http://www.spinejournal.gr/2010/04/nuvasive-reports-first-quarter-2010-financial-results/</link>
		<comments>http://www.spinejournal.gr/2010/04/nuvasive-reports-first-quarter-2010-financial-results/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 07:31:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[nuvasive]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=787</guid>
		<description><![CDATA[- Reiterates 2010 Guidance for Revenue and Earnings per Share &#8211; - Total revenue of $109.1 million &#8211; GAAP earnings of $1.1 million, or $0.03 per share; Non-GAAP earnings of $8.3 million, or $0.21 per share &#8211; Operating cash flow of $9.1 million
SAN DIEGO, April 20, 2010 /PRNewswire via COMTEX/ &#8212; NuVasive, Inc. (Nasdaq: NUVA), [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2010/04/nuvasive-reports-first-quarter-2010-financial-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Orthofix International Comments on Competitor&#8217;s Statements on Investor Call</title>
		<link>http://www.spinejournal.gr/2010/04/orthofix-international-comments-on-competitors-statements-on-investor-call/</link>
		<comments>http://www.spinejournal.gr/2010/04/orthofix-international-comments-on-competitors-statements-on-investor-call/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 06:21:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[nuvasive]]></category>
		<category><![CDATA[Orthofix]]></category>
		<category><![CDATA[Osteocell]]></category>
		<category><![CDATA[stem cell]]></category>
		<category><![CDATA[Trinity]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/2010/04/orthofix-international-comments-on-competitors-statements-on-investor-call/</guid>
		<description><![CDATA[Press Release Source: Orthofix International N.V. On Wednesday April 21, 2010
BOSTON&#8211;(BUSINESS WIRE)&#8211;Orthofix International N.V. (NASDAQ:OFIX &#8211; News) (the Company) today responded to public comments made yesterday by NuVasive, Inc. during their first quarter earnings call stating that a dispute has been initiated against the Company. The comments indicated that the dispute apparently concerns the defense [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2010/04/orthofix-international-comments-on-competitors-statements-on-investor-call/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NuVasive Initiates &#8220;Legal Dispute&#8221; Over Stem Cell IP</title>
		<link>http://www.spinejournal.gr/2010/04/nuvasive-initiates-legal-dispute-over-stem-cell-ip/</link>
		<comments>http://www.spinejournal.gr/2010/04/nuvasive-initiates-legal-dispute-over-stem-cell-ip/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 06:19:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[nuvasive]]></category>
		<category><![CDATA[Orthofix]]></category>
		<category><![CDATA[Osteocell]]></category>
		<category><![CDATA[stem cell]]></category>
		<category><![CDATA[Trinity]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=781</guid>
		<description><![CDATA[BY LAUREN UZDIENSKI, APRIL 21, 2010
Yesterday afternoon on their 1Q:10 conference call, NuVasive revealed that they initiated a &#8220;legal dispute&#8221; against Orthofix over IP related to Osteocel, the stem-cell-based bone graft substitute acquired by NuVasive from Osiris in 2008. The details of this dispute were not revealed, but NuVasive vowed to &#8220;aggressively defend&#8221; their rights [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2010/04/nuvasive-initiates-legal-dispute-over-stem-cell-ip/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NuVasive Announces Additional Insurance Provider XLIF(R) Policy Reversal</title>
		<link>http://www.spinejournal.gr/2010/03/nuvasive-announces-additional-insurance-provider-xlifr-policy-reversal/</link>
		<comments>http://www.spinejournal.gr/2010/03/nuvasive-announces-additional-insurance-provider-xlifr-policy-reversal/#comments</comments>
		<pubDate>Wed, 03 Mar 2010 08:53:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[nuvasive]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=735</guid>
		<description><![CDATA[Press Release Source: NuVasive, Inc. On Friday February 26, 2010, 4:00 pm EST
SAN DIEGO, Feb. 26 /PRNewswire-FirstCall/ &#8212; NuVasive, Inc. (Nasdaq:NUVA &#8211; News), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2010/03/nuvasive-announces-additional-insurance-provider-xlifr-policy-reversal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NuVasive Announces Preliminary Unaudited Full Year 2009 Financial Results</title>
		<link>http://www.spinejournal.gr/2010/02/nuvasive-announces-preliminary-unaudited-full-year-2009-financial-results/</link>
		<comments>http://www.spinejournal.gr/2010/02/nuvasive-announces-preliminary-unaudited-full-year-2009-financial-results/#comments</comments>
		<pubDate>Tue, 02 Feb 2010 08:32:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Alex Lukianov]]></category>
		<category><![CDATA[nuvasive]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=699</guid>
		<description><![CDATA[&#8211;Anticipates Full Year 2009 Revenue of Approximately $370 Million
&#8211;Announces Full Year 2010 Revenue Guidance of $480 Million to $500 Million
SAN DIEGO, Jan 29, 2010 /PRNewswire via COMTEX/ &#8212; NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2010/02/nuvasive-announces-preliminary-unaudited-full-year-2009-financial-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NuVasive Reports Third Quarter 2009 Financial Results</title>
		<link>http://www.spinejournal.gr/2009/10/nuvasive-reports-third-quarter-2009-financial-results/</link>
		<comments>http://www.spinejournal.gr/2009/10/nuvasive-reports-third-quarter-2009-financial-results/#comments</comments>
		<pubDate>Fri, 23 Oct 2009 05:25:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Alex Lukianov]]></category>
		<category><![CDATA[nuvasive]]></category>
		<category><![CDATA[XLIF]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=578</guid>
		<description><![CDATA[SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ &#8211; NuVasive, Inc. (Nasdaq: NUVA &#8211; News), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial results for the quarter ended September 30, 2009.
NuVasive reported third quarter revenue of $94.9 million, a 41.8% increase over the $66.9 million for the [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2009/10/nuvasive-reports-third-quarter-2009-financial-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NuVasive has agreed to purchase Cervitech</title>
		<link>http://www.spinejournal.gr/2009/05/nuvasive-has-agreed-to-purchase-cervitech/</link>
		<comments>http://www.spinejournal.gr/2009/05/nuvasive-has-agreed-to-purchase-cervitech/#comments</comments>
		<pubDate>Sun, 10 May 2009 18:13:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[cervitech]]></category>
		<category><![CDATA[nuvasive]]></category>
		<category><![CDATA[pcm]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=24</guid>
		<description><![CDATA[SAN DIEGO, April 22 /PRNewswire-FirstCall/ &#8212; NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that it has agreed to purchase Cervitech® Inc., a New Jersey based company focused on clinical approval of the PCM® cervical disc system, a motion preserving total disc replacement [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2009/05/nuvasive-has-agreed-to-purchase-cervitech/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
